中文 | English
Return
Total: 28 , 1/3
Show Home Prev Next End page: GO
Author:(Xiangyu LUO)

1.Molecular mechanism of Andrographolide on MMP-9 expression in human lung cancer cells

Xiangyu LUO ; Weimin LUO ; Xuesong ZENG

Chinese Journal of Biochemical Pharmaceutics 2014;(2):13-16

2.miR-200b suppresses proliferation and induces apoptosis in non-small cell lung cancer cells by targeting DNMT3A

Weimin LUO ; Xiangyu LUO ; Jialong GUO ; Chengyi LIN ; Jun ZHANG

Tianjin Medical Journal 2016;44(8):984-988

3.C-phycocyanin protects doxorubicin-induced myocardial cells injury by Nrf 2/heme oxygenase-1 pathway

Xiangyu LUO ; Weimin LUO ; Xuesong ZENG ; Jun ZHANG

Chinese Journal of Biochemical Pharmaceutics 2014;(2):30-32

4.Pathogenic Bacteria and Drug Sensitivity of 374 Cases of Children with Staphylococcal Scalded Skin Syn-drome

Zhu WEI ; Xiangyu LIU ; Yongqi LUO ; Xieling HE ; Jianping TANG

China Pharmacist 2016;19(6):1099-1101

5.The applied research of ultrasound-guided percutaneous thrombin injection for the treatment of Iarogenic femoral arterial complexity pseudoaneurysms

Zuoyi YAO ; Feifei LUO ; Xiangyu ZHOU ; Fang WANG

Chongqing Medicine 2017;46(4):450-452

6.Expression and significance inflammatory of cytokine mediated by Gli1 in acute pancreatitis

Kun LAI ; Xuemei HE ; Lan LUO ; Fang WANG ; Xiangyu ZHOU

Chinese Journal of Immunology 2017;33(7):1057-1061

8.Protective effect of supplementary taurine on spleen hematopoietic damage in left-half-body ionizing irradiated mice

Long YANG ; Xiangyu XU ; Chengji LUO ; Tianmin CHENG

Journal of Third Military Medical University 2003;0(21):-

9.Correlation of monocyte counts prior to the collection of recombinant human granulocyte colony-stimulating factor primed bone marrow grafts with the quantities of CD34~+ cells in the grafts.

Yingjun CHANG ; Mingrui HUO ; Xiangyu ZHAO ; Xiaohua LUO ; Xiaojun HUANG

Chinese Journal of Practical Internal Medicine 2001;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 28 , 1/3 Show Home Prev Next End page: GO